BPG is committed to discovery and dissemination of knowledge
Basic Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114286
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114286
Figure 6
Figure 6 Comparison the sensitivity of patient-derived tumor-like cell clusters to different drug regimens within individuals. A: Sensitivity of colorectal cancer (CRC)-10, CRC-32 and CRC-43 to FOLFOX and FOXFIRI; B: Sensitivity of CRC-02, CRC-35 and CRC-10 to FOLFOX, FOXFIRI and FOLFOXIRI. aP < 0.05, cP < 0.001. CRC: Colorectal cancer.


Write to the Help Desk